Literature DB >> 6612330

Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor.

W G Robison, P F Kador, J H Kinoshita.   

Abstract

A twofold thickening of capillary basement membranes of rat retinas resulting from dietary galactose was prevented by sorbinil, an inhibitor of aldose reductase. Since the basement membrane thickening was ultrastructurally similar to that typical of diabetic retinopathy, it may indicate changes in vessel permeability and susceptibility to hemorrhage. Galactosemic rats should be useful models for studying basement membrane-related complications of diabetes and for examining the potential biochemical regulation of basement membrane synthesis by aldose reductase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6612330     DOI: 10.1126/science.6612330

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  42 in total

1.  The polyol pathway in retinal microangiopathy.

Authors:  W G Robison; J H Kinoshita; P F Kador
Journal:  Drugs       Date:  1986       Impact factor: 9.546

2.  Pharmacokinetics of zopolrestat, a carboxylic acid aldose reductase inhibitor, in normal and diabetic rats.

Authors:  P B Inskeep; A E Reed; R A Ronfeld
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

3.  Dose-dependent pharmacokinetics of the aldose reductase inhibitor imirestat in man.

Authors:  R K Brazzell; P R Mayer; R Dobbs; P J McNamara; R L Teng; J T Slattery
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

4.  Vascular and Neuroepithelial Histopathology of the Saccule in Humans With Diabetes Mellitus.

Authors:  Pelin Kocdor; Serdar Kaya; Mehmet Erdil; Sebahattin Cureoglu; Michael M Paparella; Meredith E Adams
Journal:  Otol Neurotol       Date:  2016-06       Impact factor: 2.311

Review 5.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

6.  Current and future approaches in the prevention and treatment of diabetic retinopathy.

Authors:  Louis K Chang; David Sarraf
Journal:  Clin Ophthalmol       Date:  2008-06

7.  High levels of erythrocyte aldose reductase and diabetic retinopathy in NIDDM patients.

Authors:  C Nishimura; T Saito; T Ito; Y Omori; T Tanimoto
Journal:  Diabetologia       Date:  1994-03       Impact factor: 10.122

8.  Sorbitol metabolism in retina studied in vitro.

Authors:  P Naeser; S E Brolin; U J Eriksson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

9.  Intervention with the aldose reductase inhibitor, tolrestat, in renal and retinal lesions of streptozotocin-diabetic rats.

Authors:  M L McCaleb; M L McKean; T C Hohman; N Laver; W G Robison
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

10.  Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium.

Authors:  S A Vinores; E Van Niel; J L Swerdloff; P A Campochiaro
Journal:  Histochem J       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.